Keytruda cleared for NHS use in early head and neck cancer MSD's Keytruda is poised to end a 20-year drought in new advances in NHS treatment for early-stage head and neck cancer

#Keytruda #pembrolizumab #immunotherapy #headandneckcancer #PharmaNews #MSD #NICE #reimbursement #NICEfinaldraftguidance #NHSEngland #headandnecksquamouscellcarcinoma #HNSCC #LAHNSCC #PDL1biomarker #PD1inhibitor #KEYNOTE689trial #perioperativeimmunotherapy #PDL1positiveHNSCC
zurl.co/y2cQh

COPD patients will get access to Dupixent via NHS Almost 30,000 people in England with COPD stand to get access to Dupixent, the first biologic for the devastating disease, after NICE backs its use.

#COPDpatients #Dupixent #dupilumab #NHS #chronicobstructivepulmonarydisease #COPD #biologics #Sanofi #Regeneron #uncontrolledCOPD #lungdisease #COPDtherapies #NICEfinaldraftguidance #COPDflareups #COPDdiagnosis #NICE #NHScostsavings #uncontrolledCOPD #COPDcare
zurl.co/7i5io

NICE backs NHS use of Autolus' leukaemia CAR-T Hundreds of people with an aggressive leukaemia will be able to access a CAR-T therapy developed by UK biotech Autolus after a NICE recommendation.

#haematology #NICE #NHS #leukaemiaCART #Autolus #leukaemia #CARTtherapy #NHSroutinecommissioning #Aucatzyl #BcellALL #acutelymphoblasticleukaemia #relapsedALL #refractoryALL #Bcellprecursoracutelymphoblasticleukaemia #ALL #NICEfinaldraftguidance #HTA #FELIXtrial #NICEguidance
zurl.co/h6OwD

NICE recommends vutrisiran for adults with ATTR-CM in final draft guidance - PharmaTimes First long-acting therapy with three-monthly dosing to target root cause of cardiac disease

#AlnylamUK #NICE #vutrisiran #Amvuttra #ATTRCM #NICEfinaldraftguidance #transthyretinamyloidosiswithcardiomyopathy #hereditaryATTR #stage1polyneuropathy #stage2polyneuropathy #NICEfinalguidance #HELIOSBstudy #cardiovascular #stiffheartdisease #AnnaTomlinson #CardiomyopathyUK
zurl.co/0yB9A

England poised to roll out drug for rare eye disease LHON Patients in England with rare eye disorder LHON will finally get access to a Chiesi drug that has been available in the rest of the UK for years.

#Ophthalmology #eyedisease #LHON #Lebershereditaryopticneuropathy #mitochondrialgeneticdisorder #Chiesi #Raxone #idebenone #NICE #NICEfinaldraftguidance #centralvisionloss #visionloss #LHONgenes #LHONSociety #mitochondrialDNA #mtDNA #RHODOStrial #LEROStrail #PAROStrial
zurl.co/W87n3

NICE approves first immunotherapy combination for endometrial cancer NICE approves first immunotherapy combination for endometrial cancer

#womenshealth #oncology #NICE #NICErecommended #MerckSharpandDohme #MSD #immunotherapy #endometrialcancer #advancedwombcancer #wombcancer #pembrolizumab #Keytruda #NICEfinaldraftguidance #gynaecologicalcancer #UK #stage4tendometrialcancer #CancerDrugsFund
www.nice.org.uk/news/article...

Thousands more breast cancer patients to benefit from new NHS treatment

#NICE #oncology #breastcancer #breastcancerpatients #NHStreatment #NICEapproved #ribociclib #Kisqali #Novartis #earlystagebreastcancer #NICEfinaldraftguidance #aromataseinhibitor #hormonereceptorpositiveHER2negativeearlybreastcancer #Milestoneforbreastcancercare
www.nice.org.uk/news/article...

Thousands could benefit from first immunotherapy for severe birch tree pollen allergy First immunotherapy for severe birch tree pollen allergy recommended by NICE

#NICE #betulaverrucosa #Itulazax12SQBet #AlkAbelló #immunotherapy #severebirchtreepollenallergy #birchtreepollenallergy #NICErecommended #underthetonguetabletimmunotherapy #allergens #NICEfinaldraftguidance #treepollen #allergens #treepollenallergies #treepollen
www.nice.org.uk/news/article...

Final draft guidance finds benefits of 2 Alzheimer’s treatments remain too small to justify the additional costs to the NHS The benefits of Alzheimer’s treatments donanemab and lecanemab remain too small to justify the additional costs

#NICE #NICEFAD #NICEfinaldraftguidance #Alzheimerstreatments #NHS #donanemab #Kisunla #EliLilly #lecanemab #Leqembi #Eisai #negativedraftrecommendations #mildcognitiveimpairment #milddementia #Alzheimersdisease #NHSresources #NICEassessments #cognitiveimpairment
www.nice.org.uk/news/article...

NICE recommends mirikizumab for Crohn's disease treatment - PharmaTimes New guidance expands treatment options for eligible patients

#gastro #immunology #gastroenterology #mirikizumab #Omvoh #EliLilly #Crohnsdisease #Crohnsdiseasetreatment #NICE #NICEfinaldraftguidance #MHRA #marketingauthorisation #VIVID1clinicaltrial #clinicalremission #inflammatoryboweldisease #CrohnsandColitisUK
pharmatimes.com/news/nice-re...

Up to 1,000 women a year could benefit from new at-home treatment for endometriosis

#womenshealth #endometriosis #symptomsofendometriosis #NICEfinaldraftguidance #NICErecommended #NICEguidance #Linzagolix #Yselty #Theramex #endometriosissymptoms #NHSservices #medicinesevaluation #fasttrackevaluation #patientaccess #NHSinEngland
www.nice.org.uk/news/article...